Shi et alreported that lincRNA‐ROR (long intergenic non‐protein coding RNA, regulator of reprogramming) enhances cisplatin resistance by activating PI3K/Akt/mTOR signaling pathway and inhibiting mitochondrial pathway in lung cancer cells (Figure 1A).72 Here, AKT1 is linked to lung carcinoma.